Fragile X retardation syndrome corrected in miceDecember 20, 2007Researchers working with mice have significantly alleviated a wide range of abnormalities due to fragile X syndrome by altering only a single gene, countering the effects of the fragile X mutation. They said their achievement offers the potential for treatment of the disorder, the most common form of inherited mental retardation and a leading identified genetic cause of autism. There is currently no treatment or therapy for fragile X syndrome, whose symptoms include mental retardation, epilepsy, and abnormal body growth. Mark Bear and colleagues reported their findings in an article in the December 20, 2007, issue of the journal Neuron, published by Cell Press. Fragile X syndrome is known to be caused by loss of the gene for "fragile X mental retardation protein" (FMRP), which is believed to act as a brake on protein synthesis in specific areas of brain circuitry. The authors' idea was that loss of the "brake" would allow another protein that stimulates this process, called metabotropic glutamate receptor 5 (mGluR5), to function unchecked.
In their experiments to test this idea, the researchers studied mice that produce many of the characteristic pathologies of fragile X in humans due to a loss of the FMRP gene. The critical test, though, was when they also created double mutant mice that lacked both the FMRP gene and had a 50% reduction in mGluR5. They chose only to reduce the activity of the metabotropic glutamate receptor gene, rather than eliminate it, in order to reflect what might be achieved using drug treatment for fragile X in humans. Their tests on the double mutant mice revealed that the mGluR5 gene reduction greatly alleviated many abnormalities produced by loss of FMRP. The double mutant mice showed a rescue of abnormalities in brain structure and function, brain protein synthesis, memory, and body growth. For example, loss of the FMRP gene produces overgrowth of the connections among neurons called dendritic spines. However, the additional 50% reduction in mGluR5 gene produced mice with completely normal spine density. The double mutants also showed substantial reduction in epileptic seizures caused by lack of FMRP, found the researchers. They concluded that "it is remarkable that by reducing mGluR5 gene dosage by 50%, we were able to bring multiple, widely varied fragile X phenotypes significantly closer to normal." They also concluded that "These findings have major therapeutic implications for fragile X syndrome and autism." Cell Press | |||||||||||||||||||||
|
Related Retardation Current Events and Retardation News Articles Methylmercury warning Recent studies hint that exposure to the toxic chemicals, such as methylmercury can cause harm at levels previously considered safe. Scientists identify new gene responsible for puberty disorders A new gene responsible for some puberty disorders has been identified by Medical College of Georgia researchers. Rare genetic disorder gives clues to autism, epilepsy, mental retardation A rare genetic disorder called tuberous sclerosis complex (TSC) is yielding insight into a possible cause of some neurodevelopmental disorders: structural abnormalities in neurons, or brain cells. Iron-moving malfunction may underlie neurodegenerative diseases, aging A glitch in the ability to move iron around in cells may underlie a disease known as Type IV mucolipidosis (ML4) and the suite of symptoms---mental retardation, poor vision and diminished motor abilities---that accompany it, new research at the University of Michigan shows. Monitoring outcomes of suicide attempts in pregnancy can better assess drug dangers Monitoring the health of children born to women who attempted suicide while pregnant can shed light on which medicines and what doses are particularly dangerous to developing fetuses, according to researchers from Hungary who publish their findings in a series of reports in a special issue of Toxicology and Industrial Health, published this week by SAGE. Aberrations in region of chromosome 1q21.1 associated with broad range of disorders in children Researchers have discovered a submicroscopic aberration in a particular region of human chromosome 1q21.1 that appears to be associated with a variety of developmental disorders in children. The first autism disease genes The autistic disorder was first described, more than sixty years ago, by Dr. Leo Kanner of the Johns Hopkins Hospital (USA), who created the new label 'early infantile autism'. Low levels of brain chemical may lead to obesity, NIH study of rare disorder shows A brain chemical that plays a role in long term memory also appears to be involved in regulating how much people eat and their likelihood of becoming obese, according to a National Institutes of Health study of a rare genetic condition. Pregnancy situations have impact on brain development in pre-term infants Brain development in infants who are born very prematurely is still incomplete. Factors that cause premature birth may have an impact on the development of the premature infant's brain both during pregnancy and later on after birth. UC Davis researchers define characteristics, treatment options for XXYY syndrome Researchers at the UC Davis M.I.N.D. Institute and The Children's Hospital in Denver have conducted the largest study to date describing the medical and psychological characteristics of a rare genetic disorder in which males have two "X" and two "Y" chromosomes, rather than the normal one of each. More Retardation Current Events and Retardation News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||